Jeffrey L. Wade
2019
Compensation breakdown
| Bonus | $181,817 |
|---|---|
| Option Awards | $484,471 |
| Salary | $444,431 |
| Stock Awards | $491,488 |
| Other | $12,116 |
| Total | $1,614,323 |
Wade received $491.5K in stock awards, accounting for 30% of the total pay in 2019.
Wade also received $181.8K in bonus, $484.5K in option awards, $444.4K in salary and $12.1K in other compensation.
Rankings
In 2019, Jeffrey L. Wade's compensation ranked 6,965th out of 13,971 executives tracked by ExecPay. In other words, Wade earned more than 50.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,965 out of 13,971 | 50th |
Division Manufacturing | 2,663 out of 5,695 | 53rd |
Major group Chemicals And Allied Products | 973 out of 2,194 | 56th |
Industry group Drugs | 823 out of 1,880 | 56th |
Industry Pharmaceutical Preparations | 604 out of 1,392 | 57th |
Pay ratio
| Jeffrey L. Wade's Pay | $1,614,323 |
|---|---|
| Median Employee's Pay | $185,046 |
| Pay Ratio | 9to 1 |
In 2019, the annual total compensation of Jeffrey L. Wade was $1,614,323.
The annual total compensation of the median employee at Lexicon Pharmaceuticals was $185,046.
The ratio of Jeffrey L. Wade's pay to the pay of median employee was therefore 9 to one.
Wade's colleagues
We found six more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2019.
2019
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
2019
Praveen Tyle
Lexicon Pharmaceuticals
Executive Vice President, Research and Development
2019
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2019
Alexander Santini
Lexicon Pharmaceuticals
Former Executive Vice President and Chief Commercial Officer
2019
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, Innovation and Chemical Sciences
2019
Brian Crum
Lexicon Pharmaceuticals
General Counsel
News
March 26, 2024
April 8, 2022
March 19, 2021
March 13, 2020
March 14, 2019